Skip to main content

Want a detailed portfolio tracker?

Qualigen Therapeutics, Inc. Common Stock (QLGN) Operating Margin (2020 - 2022)

Qualigen Therapeutics, Inc. Common Stock (QLGN) operating margin from Jun 30, 2020 to Jun 30, 2022. The current Qualigen Therapeutics, Inc. Common Stock (QLGN) operating margin is -289.51%. You can export chart.

Annual Operating Margin

Quarterly Operating Margin

Annual Operating Margin change of Qualigen Therapeutics, Inc. Common Stock (QLGN)

YearOperating MarginChange
2021-401.06%
N/A

Comparison Qualigen Therapeutics, Inc. Common Stock (QLGN) operating margin with competitors

Qualigen Therapeutics, Inc. Common Stock (QLGN) operating margin is -289.51%.

TickerNameOperating MarginUpside
VIRVir Biotechnology Inc459241.00%-158726.72%
APLMApollomics Inc - Class A431.90%-249.18%
ABUSArbutus Biopharma Corp94.30%-132.57%
SAVACassava Sciences Inc.93.36%-132.25%
RPRXRoyalty Pharma plc - Class A89.29%-130.84%
GLPGGalapagos NV84.24%-129.10%
NEUPNeuphoria Therapeutics Inc79.85%-127.58%
BDTXBlack Diamond Therapeutics Inc77.90%-126.91%
CTNMContineum Therapeutics Inc - Class A77.87%-126.90%
CVACCureVac N.V.74.59%-125.76%
IPSCCentury Therapeutics Inc67.95%-123.47%
FULCFulcrum Therapeutics Inc65.62%-122.67%
AVIRAtea Pharmaceuticals Inc63.06%-121.78%
PLXProtalix BioTherapeutics Inc62.65%-121.64%
PRTAProthena Corporation plc58.80%-120.31%
AUPHAurinia Pharmaceuticals Inc53.31%-118.41%
ADMAAdma Biologics Inc50.90%-117.58%
RPTXRepare Therapeutics Inc50.85%-117.56%
CRMDCorMedix Inc49.96%-117.26%
HCWBHCW Biologics Inc49.45%-117.08%
CPRXCatalyst Pharmaceuticals Inc49.02%-116.93%
SRPTSarepta Therapeutics Inc49.00%-116.93%
HALOHalozyme Therapeutics Inc48.98%-116.92%
KRYSKrystal Biotech Inc46.14%-115.94%
AGENAgenus Inc44.62%-115.41%
CGENCompugen Ltd43.05%-114.87%
SVASinovac Biotech Ltd42.30%-114.61%
EXELExelixis Inc41.15%-114.21%
QTTBQ32 Bio Inc39.80%-113.75%
INVAInnoviva Inc38.94%-113.45%
VRTXVertex Pharmaceuticals Inc38.10%-113.16%
NXTCNextcure Inc36.70%-112.68%
LGNDLigand Pharmaceuticals Inc - Class B33.58%-111.60%
SLNOSoleno Therapeutics Inc33.06%-111.42%
JAZZJazz Pharmaceuticals plc31.49%-110.88%
ARGXArgen X SE30.35%-110.48%
CAICaris Life Sciences Inc - Class A30.19%-110.43%
TNGXTango Therapeutics Inc26.15%-109.03%
GMABGenmab25.11%-108.67%
ZVRAZevra Therapeutics Inc24.40%-108.43%
TECHBio-Techne Corp24.24%-108.37%
INCYIncyte Corp23.66%-108.17%
RIGLRigel Pharmaceuticals20.21%-106.98%
ICCCImmucell Corp19.01%-106.57%
REGNRegeneron Pharmaceuticals Inc17.83%-106.16%
NERVMinerva Neurosciences Inc17.73%-106.12%
HRMYHarmony Biosciences Holdings Inc17.31%-105.98%
TGTXTG Therapeutics Inc16.98%-105.87%
BMRNBiomarin Pharmaceutical Inc16.92%-105.84%
ONCBeiGene Ltd16.51%-105.70%
PTCTPTC Therapeutics Inc16.50%-105.70%
PHARPharming Group N.V.16.26%-105.62%
ENVBEnveric Biosciences Inc13.38%-104.62%
VXRTVaxart Inc13.19%-104.56%
VRNAVerona Pharma Plc12.90%-104.46%
ALNYAlnylam Pharmaceuticals Inc12.01%-104.15%
ASNDAscendis Pharma A/S10.06%-103.47%
APLSApellis Pharmaceuticals Inc9.86%-103.41%
FOLDAmicus Therapeutics Inc8.61%-102.97%
CGEMCullinan Oncology Inc7.24%-102.50%
IMCRImmunocore Holdings plc6.82%-102.36%
NAGENiagen Bioscience Inc5.01%-101.73%
NUVBNuvation Bio Inc - Class A4.66%-101.61%
BMEABiomea Fusion Inc2.46%-100.85%
TLXTelix Pharmaceuticals Ltd1.58%-100.55%
HOTHHoth Therapeutics Inc0.17%-100.06%
BBLGBone Biologics Corp0.04%-100.01%